Kyowa Kirin Co (TSE:4151) FCF Margin % : 16.21% (As of Sep. 2023)

View and export this data going back to 1949. Start your Free Trial

What is Kyowa Kirin Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Kyowa Kirin Co's Free Cash Flow for the three months ended in Sep. 2023 was 円17,319 Mil. Kyowa Kirin Co's Revenue for the three months ended in Sep. 2023 was 円106,844 Mil. Therefore, Kyowa Kirin Co's FCF Margin % for the quarter that ended in Sep. 2023 was 16.21%.

As of today, Kyowa Kirin Co's current FCF Yield % is 4.34%.

The historical rank and industry rank for Kyowa Kirin Co's FCF Margin % or its related term are showing as below:

TSE:4151' s FCF Margin % Range Over the Past 10 Years
Min: -4.58 Med: 10.58 Max: 18.96
Current: 14.52

During the past 13 years, the highest FCF Margin % of Kyowa Kirin Co was 18.96%. The lowest was -4.58%. And the median was 10.58%.

TSE:4151's FCF Margin % is ranked better than
83.54% of 1027 companies
in the Drug Manufacturers industry
Industry Median: -0.12 vs TSE:4151: 14.52

Kyowa Kirin Co FCF Margin % Historical Data

The historical data trend for Kyowa Kirin Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyowa Kirin Co FCF Margin % Chart

Kyowa Kirin Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

FCF Margin %

Get a 7-Day Free Trial

15.63

10.59

1.34

18.96

5.02

Kyowa Kirin Co Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
FCF Margin %	Get a 7-Day Free Trial															7.34	-0.76	21.83	22.89	16.21

Competitive Comparison of Kyowa Kirin Co's FCF Margin %

For the Drug Manufacturers - General subindustry, Kyowa Kirin Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kyowa Kirin Co's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kyowa Kirin Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Kyowa Kirin Co's FCF Margin % falls into.

Kyowa Kirin Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Kyowa Kirin Co's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	20006	/	398371
	=	5.02 %

Kyowa Kirin Co's FCF Margin for the quarter that ended in Sep. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2023 )	/	Revenue (Q: Sep. 2023 )
	=	17319	/	106844
	=	16.21 %

Kyowa Kirin Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Kyowa Kirin Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Kyowa Kirin Co (TSE:4151) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyowa Kirin Co Ltd (TSE:4151) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

KYKOY:USA KYKOF:USA

Address

1-9-2,Otemachi, Chiyoda-ku, Otemachi Financial City Grand Cube, Tokyo, JPN, 100-0004

Website

http://www.kyowa-kirin.com

Kyowa Kirin Co Ltd is a drug manufacturing company that focuses on biologic medicines. Its operations emphasize four categories: nephrology, oncology, immunology and allergy, and the central nervous system. The company has two reportable segments, Pharmaceuticals and Biochemicals. The pharmaceuticals business manufactures and sells ethical pharmaceuticals, diagnostic reagents, and other products. The biochemicals business manufactures and sells raw materials for pharmaceutical and industrial use, mainly amino acids, nucleic acids and related compounds, healthcare products, and others.

Kyowa Kirin Co (TSE:4151) Headlines

No Headlines